Haploidentical peripheral blood stem cell transplantation (Haplo-PBSCT) is a promising
treatment option for patients with Ph-negative acute lymphoblastic leukemia (ALL). In this …

Unmanipulated haploidentical hematopoietic stem cell transplantation (HCT) with post-
transplantation cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis (haplo …

The clinical outcome of primary refractory (PRF) AML patients is poor and only a minor
proportion of patients is rescued by allogenic hematopoietic stem cell transplantation …

Because a pediatric-inspired Group for Research on Adult Acute Lymphoblastic Leukemia
(GRAALL) protocol yielded a markedly improved outcome in adults with Philadelphia …

Autologous stem cell transplantation (ASCT), intensifying anti-leukemic effects without
significant treatment-related mortality (TRM), is particularly appealing in AML with favorable …

Background Primary refractory acute myeloid leukemia (prAML) is a poor prognosis disease
for which allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative …

Background Achieving complete remission (CR) is the main goal in AML treatment and a
prerequisite for successful autologous stem cell transplantation (ACT). Methods Comparing …

Limited data are currently available on the outcome of patients with acute myeloid leukemia
(AML) undergoing allogeneic stem cell transplantation (allo‐SCT) with a reduced …

Aims Allogeneic stem cell transplantation (alloSCT) in first complete remission (CR1) has
become a standard of care for many patients (pts) with intermediate or high risk acute …

Stem cell transplantation (SCT) is an attractive postremission treatment option for patients
with intermediate-risk acute myeloid leukemia (AML) and for some favorable-risk AML …